A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
about
Effects of glucocorticoids on radiological progression in rheumatoid arthritisMeta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsEffect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analysesHistone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Glucocorticoids in rheumatoid arthritis.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.Optimizing current treatment of gout.When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.Glucocorticoid treatment in rheumatoid arthritis.Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis.2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
P2860
Q24243070-72FE260C-6DDB-40F7-8551-119F4F936A47Q27025358-D3E37850-F974-4FD9-8CA9-9153A7DC4C66Q28543128-2FAC3943-3D29-4DC8-96D5-48A29CD16CF5Q34500921-57242D33-E8D1-483B-B17E-B8612967C84EQ35617753-3E3AEE32-A205-457D-A763-CD8A04AE78CBQ38008692-FEC27D16-3316-4AA3-ACE6-2D840519A552Q38075503-AB8CD8D6-74F1-4CF8-8F2F-933C9996CEC9Q38168952-58886732-0105-4A31-BCAE-7C9DBACCA9FAQ38194896-17B67653-6110-436B-AE20-934D3B0CB396Q38211695-1B274B32-9E73-4CB7-B1BC-C793BB2EA949Q38214242-0E6265BC-4A5F-4262-B5AA-9B4F62C46001Q46008683-6C95DF24-E33E-4A4E-A5B8-8C67B02FE647Q57245378-1F2E3CC8-CF53-4940-8687-9C136BB9671B
P2860
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A two year randomised controll ...... modifying antirheumatic drugs.
@ast
A two year randomised controll ...... modifying antirheumatic drugs.
@en
type
label
A two year randomised controll ...... modifying antirheumatic drugs.
@ast
A two year randomised controll ...... modifying antirheumatic drugs.
@en
prefLabel
A two year randomised controll ...... modifying antirheumatic drugs.
@ast
A two year randomised controll ...... modifying antirheumatic drugs.
@en
P2093
P2860
P356
P1476
A two year randomised controll ...... modifying antirheumatic drugs.
@en
P2093
G H Kingsley
Intramuscular Methylprednisolone Study Group
N Pipitone
P2860
P304
P356
10.1136/ARD.2004.030908
P407
P577
2005-03-10T00:00:00Z